CV Sciences Inc
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributor… Read more
Market Cap & Net Worth: CV Sciences Inc (CVSI)
CV Sciences Inc (OTCQB:CVSI) has a market capitalization of $5.53 Million ($5.53 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #31223 globally and #10274 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CV Sciences Inc's stock price $0.03 by its total outstanding shares 184263663 (184.26 Million).
CV Sciences Inc Market Cap History: 2015 to 2025
CV Sciences Inc's market capitalization history from 2015 to 2025. Data shows change from $44.32 Million to $5.53 Million (-28.93% CAGR).
CV Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CV Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.47x
CV Sciences Inc's market cap is 0.47 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $44.32 Million | $11.53 Million | -$12.23 Million | 3.84x | N/A |
| 2016 | $79.23 Million | $11.06 Million | -$14.14 Million | 7.16x | N/A |
| 2017 | $113.78 Million | $20.68 Million | -$4.90 Million | 5.50x | N/A |
| 2018 | $794.18 Million | $48.24 Million | $10.00 Million | 16.46x | 79.41x |
| 2019 | $177.81 Million | $53.70 Million | -$16.61 Million | 3.31x | N/A |
| 2020 | $86.60 Million | $24.43 Million | -$22.28 Million | 3.55x | N/A |
| 2021 | $22.11 Million | $20.05 Million | -$15.55 Million | 1.10x | N/A |
| 2022 | $5.53 Million | $16.20 Million | -$8.21 Million | 0.34x | N/A |
| 2023 | $7.37 Million | $16.00 Million | $3.10 Million | 0.46x | 2.38x |
| 2024 | $7.37 Million | $15.71 Million | -$2.39 Million | 0.47x | N/A |
Competitor Companies of CVSI by Market Capitalization
Companies near CV Sciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to CV Sciences Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
CV Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, CV Sciences Inc's market cap moved from $44.32 Million to $ 5.53 Million, with a yearly change of -28.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $5.53 Million | -25.00% |
| 2024 | $7.37 Million | 0.00% |
| 2023 | $7.37 Million | +33.33% |
| 2022 | $5.53 Million | -75.00% |
| 2021 | $22.11 Million | -74.47% |
| 2020 | $86.60 Million | -51.30% |
| 2019 | $177.81 Million | -77.61% |
| 2018 | $794.18 Million | +597.98% |
| 2017 | $113.78 Million | +43.60% |
| 2016 | $79.23 Million | +78.79% |
| 2015 | $44.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CV Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.53 Million USD |
| MoneyControl | $5.53 Million USD |
| MarketWatch | $5.53 Million USD |
| marketcap.company | $5.53 Million USD |
| Reuters | $5.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.